American Conference Institute’s Biosimilars & Innovator Biologics

Intellectual Property partner Jonathan S. Caplan will speak at the American Conference Institute’s Biosimilars & Innovator Biologics summit, being held virtually on June 22 – 23, 2021. Jonathan will take part in a panel discussion titled “Think Tank on State and Federal Antitrust Initiatives: Commercial Considerations for Patent Settlements, Reverse Payments, and Emerging Legislation.” Kramer Levin is also a sponsor of the conference.

More information, including how to register, is available here.